QUOTE AND NEWS
StreetInsider.com  May 13  Comment 
DXP Enterprises, Inc. (Nasdaq: DXPE) 38.5% LOWER; reported Q1 EPS of $0.75, may not compare to the analyst estimate of $1.17. Revenue for the quarter came in at $348.5 million versus the consensus estimate of $378 million. Gold Resource...
TheStreet.com  May 13  Comment 
NEW YORK (TheStreet) -- Telik  soared Tuesday after Monday's announcement that the oncology drug development company had entered into a definitive merger agreement with privately held MabVax Therapeutics.  The two companies will combine into...
Benzinga  May 12  Comment 
MabVax Therapeutics, Inc., a privately held cancer immunotherapy company and Telik, Inc. (Nasdaq: TELK), aclinical stage oncology drug development company have entered into a definitive merger agreement. Upon closing of the transaction, MabVax...
The Hindu Business Line  Feb 4  Comment 
With consistent capacity augmentation, TELK plans to touch 12,000 MvA by 2017. It is currently evaluating other options to diversify into other links of the power value chain, such as solar power generation and EPC contracts.
The Hindu Business Line  Feb 1  Comment 
Excise Minister K. Babu will inaugurate the renovated and modernised plant of TELK at Angamaly on Saturday. The new facility in the plant included extension of the shop floor area, const...
Benzinga  Jan 22  Comment 
Telik, Inc. (Nasdaq: TELK) announced the completion of an End of Phase 2 meeting with the US Food and Drug Administration (FDA).  Preliminary agreement was reached regarding the design of a Phase 3 placebo-controlled randomized registration trial...
StreetInsider.com  Jan 14  Comment 
Aurizon Mines Ltd. (AMEX: AZK) 33.1% HIGHER; Alamos Gold to acquire Aurizon for C$4.65 per share. Click here for more color. Telik, Inc. (Nasdaq: TELK) 21.1% LOWER; was notified last Friday that its product candidate, ezatiostat HCL (Telintra),...
Benzinga  Jan 14  Comment 
Chyron (NASDAQ: CHYR) shares dipped 15.38% to $0.88 at 9:50 am. Chyron's trailing-twelve-month ROE is -11.24%. Telik (NASDAQ: TELK) dropped 14.43% to $2.55. Telik has been granted orphan drug designation by the US FDA for the treatment of...
Benzinga  Jan 12  Comment 
Telik (NASDAQ: TELK) was notified today that its product candidate, ezatiostat HCL (Telintra), has been granted orphan drug designation by the US Food and Drug Administration (FDA) for the treatment of myelodysplastic syndrome (MDS).  Orphan...
The Hindu Business Line  Dec 14  Comment 
Transformers and Electricals Kerala Ltd (TELK) is looking forward to play an active role in the transformer market space for 220kV/400kV/765kV voltage levels. For this, the company offic...





 




References

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki